Back to top

Image: Bigstock

Zacks.com highlights: Bristol-Myers Squibb, Quintiles IMS Holdings, Intel, CoreSite Realty and Curtiss-Wright

Read MoreHide Full Article

For Immediate Release

Chicago, IL – November 3, 2017 - Stocks in this week’s article include: Bristol-Myers Squibb Company (BMY - Free Report) , Quintiles IMS Holdings, Inc. , Intel Corporation (INTC - Free Report) , CoreSite Realty Corporation (COR - Free Report) and Curtiss-Wright Corporation (CW - Free Report) .

Screen of the Week of Zacks Investment Research:

Upgraded Broker Ratings Make These 5 Stocks Good Investments

With the third-quarter earnings season continuing in full swing, investors are keeping an eye on the financial performance of companies. But betting on stocks just based on their quarterly performances is not the correct long-term investment strategy.

Several technical and fundamental aspects need to be taken into consideration while choosing stocks with steady performance. Therefore, some expert advice comes in handy while selecting such stocks.

One can easily pick attractive stocks by following broker upgrades. They have deeper understanding of what’s happening in a particular company. Also, they comprehensively analyze the strengths and weaknesses of a company and consider them against the present economic backdrop to figure out how the stock will fare as an investment.

Also, brokers directly communicate with top management, attend conference calls and go through the company’s publicly available financial documents. They even talk to customers to understand their likes/dislikes for the products and services offered by the company.

So, when a broker upgrades a stock, one can definitely rely on it. But merely depending on it is not wise. One must take into consideration several other factors to ensure strong returns.

Selecting the Winning Strategy

We have a screening strategy that will help in your search for potential winners:

Broker Rating Upgrades (4 weeks) of 1% or more:The screen selects stocks that have witnessed broker rating upgrades of 1% more over the last four weeks.

Current Price greater than 5:The stocks must be trading above $5.

Average 20-day Volume greater than 100,000:A large trading volume guarantees that the stock is easily tradable.

Zacks Rank equal to #1 or #2:No matter whether market conditions are good or bad, stocks with a Zacks Rank #1 (Strong Buy) or #2 (Buy) have a proven record of success. You can see the complete list of today’s Zacks #1 Rank stocks here.

VGM Score equal to A or B: Our research shows that stocks with a VGM Score of A or B when combined with a Zacks Rank #1 or 2 offer the best upside potential.

Here are five of the seven stocks that made it through the screen:

Headquartered in New York, Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, markets, and distributes biopharmaceutical products. The company’s earnings are expected to grow 5.7% in the current year. The stock has witnessed 6.7% upward revision in broker ratings over the past four weeks.

Quintiles IMS Holdings, Inc., headquartered in Durham, NC, provides integrated information and technology-enabled healthcare services. The company’s current year earnings are expected to grow 18%. The stock has witnessed 5.9% upward revision in broker ratings over the past four weeks.

Santa Clara, CA-based Intel Corporation designs, manufactures, and sells computer, networking, and communications platforms. The company’s earnings are expected to grow 17.9% this year. The stock has witnessed 4.4% upward revision in broker ratings over the past four weeks.

CoreSite Realty Corporation, based in Denver, CO, is engaged in the ownership, acquisition, construction, and management of data centers. The company’s current year earnings are expected to grow at the rate of 191.2%. The stock has witnessed 7.7% upward revision in broker ratings over the past four weeks.

Headquartered in Charlotte, NC, Curtiss-Wright Corporation designs, manufactures, overhauls precision components, and engineered products and services. The company’s earnings are expected to grow 13% in the current year. The stock has witnessed 12.5% upward revision in broker ratings over the past four weeks.

Get the remaining stocks on the list and start putting this and other ideas to the test. It can all be done with the Research Wizard stock picking and back testing software.

The Research Wizard is a great place to begin. It's easy to use. Everything is in plain language. And it's very intuitive. Start your Research Wizard trial today. And the next time you read an economic report, open up the Research Wizard, plug your finds in, and see what gems come out.

Click here to sign up for a free trial to the Research Wizard today.

Disclosure: Officers, directors and/or employees of Zacks Investment Research may own or have sold short securities and/or hold long and/or short positions in options that are mentioned in this material. An affiliated investment advisory firm may own or have sold short securities and/or hold long and/or short positions in options that are mentioned in this material.

About Screen of the Week

Zacks.com created the first and best screening system on the web earning the distinction as the "#1 site for screening stocks" by Money Magazine.  But powerful screening tools is just the start. That is why Zacks created the Screen of the Week to highlight profitable stock picking strategies that investors can actively use.

Strong Stocks that Should Be in the News

Many are little publicized and fly under the Wall Street radar. They're virtually unknown to the general public. Yet today's 220 Zacks Rank #1 "Strong Buys" were generated by the stock-picking system that has more than doubled the market from 1988 through 2016. Its average gain has been a stellar +25% per year. See these high-potential stocks free >>.

Follow us on Twitter:  https://twitter.com/zacksresearch

Join us on Facebook:  https://www.facebook.com/ZacksInvestmentResearch

Zacks Investment Research is under common control with affiliated entities (including a broker-dealer and an investment adviser), which may engage in transactions involving the foregoing securities for the clients of such affiliates.

Contact: Jim Giaquinto

Company: Zacks.com

Phone: 312-265-9268

Email: pr@zacks.com

Visit: https://www.zacks.com/

Zacks.com provides investment resources and informs you of these resources, which you may choose to use in making your own investment decisions. Zacks is providing information on this resource to you subject to the Zacks "Terms and Conditions of Service" disclaimer. www.zacks.com/disclaimer.

Past performance is no guarantee of future results. Inherent in any investment is the potential for loss. This material is being provided for informational purposes only and nothing herein constitutes investment, legal, accounting or tax advice, or a recommendation to buy, sell or hold a security. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. It should not be assumed that any investments in securities, companies, sectors or markets identified and described were or will be profitable. All information is current as of the date of herein and is subject to change without notice. Any views or opinions expressed may not reflect those of the firm as a whole. Zacks Investment Research does not engage in investment banking, market making or asset management activities of any securities. These returns are from hypothetical portfolios consisting of stocks with Zacks Rank = 1 that were rebalanced monthly with zero transaction costs. These are not the returns of actual portfolios of stocks. The S&P 500 is an unmanaged index. Visit https://www.zacks.com/performance for information about the performance numbers displayed in this press release.